NAVACAPRANT

UNII:	XK5ILZ28KI
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₃₂FN₅O₂
Preferred Substance Name:	NAVACAPRANT
InChIKey:	CQOJHAJWCDJEAT-UHFFFAOYSA-N
GSRS Full Record:	XK5ILZ28KI i

2244614-14-8
1-[6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-4-piperidinamine
1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5- yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine
4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-
BTRX-140
BTRX-335140
BTRX335140
CYM-53093
CYM53093
NAVACAPRANT [USAN]
NMRA-140
NMRA-335140
NMRA335140
Navacaprant
navacaprant [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

NAVACAPRANT

Synonyms and Mappings

Resources